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Abstract
Background: Blood lead has been associated with an elevated risk of miscarriage. The plasmatic fraction of lead
represents the toxicologically active fraction of lead. Women with a tendency to have a higher plasma/whole blood Pb
ratio could tend towards an elevated risk of miscarriage due to a higher plasma Pb for a given whole blood Pb and would
consequently have a history of spontaneous abortion.
Methods: We studied 207 pregnant Mexico City residents during the 1st trimester of pregnancy, originally recruited for
two cohorts between 1997 and 2004. Criteria for inclusion in this study were having had at least one previous pregnancy,
and having valid plasma and blood Pb measurements. Pb was measured in whole blood and plasma by inductively coupled
plasma mass spectrometry using ultra-clean techniques. History of miscarriage in previous pregnancies was obtained by
interview. The incidence rate of spontaneous abortion was defined as the proportion of previous pregnancies that
resulted in miscarriage. Data were analyzed by means of Poisson regression models featuring the incidence rate of
spontaneous abortion as the outcome and continuous or categorized plasma/blood Pb ratios as predictor variables. All
models were adjusted for age and schooling. Additionally, logistic regression models featuring inclusion in the study
sample as the outcome were fitted to assess potential selection bias.
Results: The mean number of miscarriages was 0.42 (range 0 to 4); mean Pb concentrations were 62.4 and 0.14 µg/L in
whole blood and plasma respectively. Mean plasma/blood Pb ratio was 0.22%. We estimated that a 0.1% increment in
the plasma/blood Pb ratio lead was associated to a 12% greater incidence of spontaneous abortion (p = 0.02). Women
in the upper tertile of the plasma/blood Pb ratio had twice the incidence rate of those in the lower tertile (p = 0.02).
Conditional on recruitment cohort, inclusion in the study sample was unrelated to observable characteristics such as
number of abortions, number of pregnancies, blood Pb levels, age schooling, weight and height.
Conclusion: Women with a large plasma/whole blood Pb ratio may be at higher risk of miscarriage, which could be due
to a greater availability of placental barrier-crossing Pb.
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Several studies have reported a positive association
between maternal blood lead concentration and the risk
of spontaneous abortion [1-3]. This is of concern since
one of these studies showed an important increase in the
risk of miscarriage even among women with low to mod-
erate blood lead levels [1]. However, previous studies
were not conclusive, which could be attributed to meth-
odological problems in study designs [4].
An additional explanation for the inconclusive results is
that blood Pb may not be the optimal biomarker to assess
lead exposure. Over 99 percent of blood Pb is bound to
erythrocytes, which cannot cross the placental barrier,
thus, plasma lead concentration has been suggested as a
better surrogate for the toxicologically active fraction of
lead in blood [5,6]. This has been substantiated by the
findings that plasma Pb was a greater predictor of toxicity
on hematopoiesis than blood Pb [7], and of delays in neu-
robehavioral development after fetal exposure to Pb [8].
To our knowledge, only one study assessed whether
plasma lead concentrations where associated to the occur-
rence of miscarriage, and although the authors could not
find an association [9], their study had a rather small sam-
ple size (n = 40), and plasma lead has a large inter-indi-
vidual variability [10,11]. The latter could make it difficult
to find associations if the time between the exposure
measurement and the event is relatively large.
To date, there have been no studies relating the plasma/
whole blood Pb ratio, with adverse health outcomes. It
has been previously shown that the plasma whole/blood
Pb ratio is highly influenced by interindividual factors
[12]. Such factors could be polymorphic alleles of genes
coding for proteins involved in the partitioning of circu-
lating lead, the most important being δ-aminolevulinic
acid dehydratase (ALAD), among other unidentified
binding sites for lead [13,14]. A recent contribution
described that polymorphisms in the ALAD genes are
strongly associated to plasma/blood Pb ratios [15]. This
finding raises the possibility that fetuses of women with a
tendency to have a lower erithrocytic lead binding capac-
ity, reflected in higher plasma/blood Pb ratios, and conse-
quently greater plasma Pb levels for a given whole blood
Pb concentration, would be more exposed to lead and at
a greater risk of reproductive toxicity [11]; under this
hypothesis, current blood or plasma Pb would not neces-
sarily be strongly associated to history of miscarriage,
since blood or plasma Pb concentrations are more
dependent on intra-individual temporal variation than
plasma/blood Pb ratios and would therefore be less corre-
lated between pregnancies. Also, if this hypothesis is true
then the plasma/blood Pb ratio could be viewed as a
marker of susceptibility for the toxic effects of Pb. To test
this hypothesis, we examined the association between the
plasma/blood Pb ratio and the past history of miscar-
riages among two cohorts of pregnant women residing in
Mexico City.
Methods
Study population
We conducted a nested cross-sectional study on 207
healthy pregnant women, recruited to participate in two
larger cohort studies. The first cohort was recruited from
May 1997 through July 1999, and the 2nd from January
2001, to April 2004. The original objectives of the first
cohort were to assess lead toxicokinetics and bone metab-
olism during pregnancy, as well as investigating a possible
link between prenatal exposure to lead and neurodevelop-
ment later in life. The second cohort was a randomized
clinical trial to evaluate the efficacy of a calcium supple-
mentation during pregnancy on diminishing blood Pb
concentration. Inclusion & exclusion criteria for both
cohorts were the same: participants were selected from
healthy pregnant women with a maximum of 14 weeks of
gestation with a confirmed positive beta-HCG test, who
were invited to participate during their prenatal care visits
to one of three clinics of the Mexican Institute of Social
Security (IMSS) in the Mexico City area. Exclusion criteria
were not being a resident of Mexico City or having plans
to leave the area in the following 5 years, having a psychi-
atric disorder, daily consumption of alcoholic beverages,
addiction to illegal drugs, continuous use of prescription
drugs, diagnosis of high-risk pregnancy, preeclampsia,
renal or circulatory disease including hypertension, gesta-
tional diabetes, suffering from seizures that required med-
ical treatment and being pregnant with more than 14
weeks of gestation. A total of 327 and 670 subjects were
enrolled in the first and second cohorts respectively. How-
ever, due mainly to budget considerations, only 194 sub-
jects of the 1st cohort and 118 of the second cohort had
valid measurements of blood and plasma Pb in the 1st tri-
mester of pregnancy and provided information on history
of abortion, Of these 312 subjects, 105 women with no
previous pregnancies were excluded from this analysis
since they had not been in risk of suffering an abortion
(see statistical analysis section). In conclusion, the final
sample was comprised of 207 women; 130 and 77 from
the first and second cohorts, respectively (Figure 1).
All subjects were informed in detail about the nature and
aims of the research studies and received information on
ways to minimize their exposure to Pb. Those who
accepted to participate read and signed a letter of
informed consent. The research protocols were approved
by the Ethics Committee of the National Institute of Pub-
lic Health of Mexico and the Institutional Review Board of
the Harvard University School of Public Health.Page 2 of 8
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Assessment of outcome and covariates
We collected information on reproductive history by
interviewing the participants during their first visit to the
Center for Environmental Health Research of the Ameri-
can British Cowdray (ABC) Hospital in Mexico City, Mex-
ico, scheduled at 12 weeks (± 2 weeks) of pregnancy.
Information on the number of lifetime spontaneous abor-
tions was collected via the question: How many miscar-
riages (losses of pregnancy) have you had?. Information on
other reproductive history variables, diet, anthropometry,
schooling and possible exposure to Pb was also collected
by interview. The interviews and anthropometry were per-
formed by previously standardized personnel.
Blood and plasma lead measurement
Blood and plasma samples were collected during each
visit of the subjects to the research center. Subjects were
instructed to fast overnight prior to sample collection.
Prior to venipuncture, each subject's arm was washed with
ultrapure water and disinfected with reagent-grade alco-
hol. Three cm3 of venous whole blood was collected with
a butterfly catheter (19 gauge) into a low lead container
(Vacutainer, B-D 367734; Becton-Dickinson, Franklin
Lakes, NJ) for blood lead analysis, and 13 cm3 of venous
blood was then collected into a polyethylene tube con-
taining 100 USP of sodium heparin (H-3393; Sigma
Chemical Company, St. Louis, MO), processed and
shipped to the trace metal facility at the University of Cal-
ifornia, Santa Cruz for measurement of whole blood lead
and plasma lead using ultra-clean methods detailed else-
where [16]. All samples were analyzed using Inductively
Coupled Plasma Mass Spectrometry (ICP-MS, Thermo
Finnigan, Bremen, Germany). Potential contamination by
lead from hemolyzed red cells was assessed by measuring
levels of plasma iron and free hemoglobin using methods
previously described in detail [12,16]. Using these proce-
dures, 14 samples were determined to be contaminated
with Pb from hemolysis suffered during sample collection
and excluded from further analyses.
Cord blood was obtained when the subjects gave birth
and was analyzed for Pb concentrations using a graphite
furnace atomic absorption spectrophotometer (Perkin-
Elmer 2100, Wellesley, MA, USA) at the trace metal labo-
ratory of the ABC hospital in Mexico City. All sample col-
lections were performed by personnel trained and
standardized for the collection of blood and plasma fol-
lowing previously reported ultra clean procedures
[12,16].
Bone Pb measurement
Valid data on patellar and tibial bone Pb concentrations
(excluding measurements with uncertainties greater than
15 or 10 ppb of Pb for patella and tibia respectively) were
available in a subsample of 153 and 95 women respec-
tively. The measurements were obtained within four
weeks of delivery using a spot-source 109Cd K-XRF instru-
ment constructed at Harvard University and installed in a
research facility in the American British Cowdray Medical
Center. Thirty minutes of measurements were performed
on the patella and midtibial shaft of each leg, representing
trabecular and cortical bone, respectively.
Statistical Analysis
Descriptive statistics were obtained and simple non-para-
metric statistical comparisons (Mann-Whitney test) were
performed between those with no history of miscarriage
vs. those with one or more events. A simple linear regres-
sion model of the plasma-to-blood Pb ratio was fitted to
assess the relationship between this marker and the
number of lifetime abortions; for this model, loge trans-
formation of the plasma/blood Pb ratio was used to
achieve a normal distribution of the residuals. Adjusted
Incidence Rate Ratios (IRR) were estimated by fitting a
Poisson regression model. Since women are only at risk of
suffering miscarriage during pregnancy and consequently
those with a larger number of pregnancies were at a larger
risk of suffering a miscarriage, we defined the Incidence
Rate of miscarriages for subject i as:
ri = mi/pi (1)
Composition of the study sample. Mexico City, Mexico, 1997–2004Figure 1
Composition of the study sample. Mexico City, Mex-
ico, 1997–2004. Composition of the sample in a study to 
evaluate the association between plasma/blood Pb ratios and 
history of spontaneous abortion.
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subject (i = 1, ..., n), mi is the number of miscarriages for
the i-th subject and pi is the number of previous pregnan-
cies. The current pregnancy was not considered as time of
exposure since being currently pregnant was an inclusion
criterion for all studied women. This means that subjects
must not have an abortion in order to reach the first tri-
mester of pregnancy and be included in the sample and
thus none of them were "at risk" of having a miscarriage.
It follows that the Incidence Rate of miscarriage was not
defined for those with no previous pregnancies and there-
fore these women were not included in the analysis. Based
on these considerations, we fitted the following Poisson
regression model of the Incidence Rate of miscarriage:
ri = exp{β0 + β1RATIOi + β2YSCHi + β3AGEi} (2)
Where RATIOi is the plasma/blood Pb ratio, YSCHi are the
number of years in school and AGEi is the age of the i-th
subject. A second Poisson model features tertiles of the
Plasma/Blood Pb ratio as an explanatory variable. Alter-
native models were fitted where whole blood Pb, plasma
Pb and bone Pb were included as explanatory variables
instead of the Plasma/Blood Pb ratio, these latter models
included standardized independent variables, and the
estimated IRRs are per one standard-deviation change in
the explanatory variable. A secondary analysis was carried
out to assess the possible correlation between cord blood
lead levels during pregnancy and the plasma/blood Pb
ratio; this hypothesis was tested by means of Cuzick's
non-parametric test for trend.
Procedures for testing the Poisson assumption
In order to verify the adequacy of fitting Poisson regres-
sion models to spontaneous abortion incidence, we veri-
fied the assumption that spontaneous abortion data are
Poisson distributed. We tested this assumption using
three different approaches. The first two are based on the
variance-to-mean ratio and the third one is based on the
properties of the probability-generating function. Besides
the χ2-test, one of the most common tests for verifying the
Poisson assumption is the variance test (VT), also known
as the index of dispersion test [17]:
It is known that VT/(n-1) is asymptotically a χ2-distribu-
tion with 1 degree of freedom. The power of the VT
depends on the distribution under the alternative hypoth-
esis. For spontaneous abortion data: VT/(n-1) =1.0676,
χ20.5,1 = 3.841, p = 0.3014. The asymptotically locally most
powerful test (among all locally unbiased tests for testing
the Poisson assumption against a mixed Poisson distribu-
tion) is given by Böhning [18], and Karlis & Xekalaki [19]:
This statistic is asymptotically standard normal distrib-
uted. For spontaneous abortion data: O2 = 0.6063, Z0.5 =
1.96, p = 0.4925. The probability generating function φ(t)
of a Poisson distribution with mean λ, satisfies the rela-
tionship [20]:
that is, the function log(φ(t)) is a straight line with slope
equal to the mean value λ.
Let Yn(t) denote the sample version of log(φ(t)):
Therefore, under the Poisson hypothesis and when n is
large, the shape of Yn(t) is nearly a straight line. For the
spontaneous abortion data,φn(t) simplifies as :
The behavior of Yn(t), based on one hundred randomly
chosen values of t within the interval (0,1), was practically
a straight line. The slope of the fitting a regression model
for these points was 0.4191 practically equal to the mean
of the number of miscarriages. All three tests indicate a
high agreement with the Poisson assumption.
Results
Descriptive statistics are presented in table 1. Age ranged
from 17 to 43 years, the number of years in school varied
between zero and 18, and the number of previous preg-
nancies ranged between 1 and 5. Average plasma/blood
Pb ratio was 0.22 percent (range: 0.01 to 0.99 percent),
history of abortions ranged from 0 to 4 (mean: 0.42), 34.3
percent of the women reported having experienced at least
one miscarriage and 4.3 percent reported having had two
or more. Women who reported having had at least one
abortion were in average slightly less educated (9.49 vs.
9.22 years in school) and had a higher average number of
pregnancies (2.16 vs. 1.38) than women with no previous
abortions. Women with a history of miscarriage had a
comparatively higher mean plasma/blood Pb ratio rela-
tive to those with no history.
There appears to be a linear trend of the plasma/blood Pb
ratio according to the reported number of lifetime abor-
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model, women with one additional abortion have an 18
percent greater plasma-to-blood Pb ratio (p < 0.01), this
relationship held even after removing the three subjects
with more than 2 miscarriages (16 percent greater plasma/
blood Pb per additional abortion, p = 0.02). Additionally,
adjusting for the number of pregnancies did not have a
noticeable impact in the coefficient estimate (19 percent
greater plasma/blood Pb per additional abortion, p <
0.01).
Women in the upper tertile of the plasma/blood Pb ratio
during the 1st trimester of pregnancy had almost twice the
incidence rate of reported spontaneous abortions com-
pared to women in the lower tertile, (IRR = 1.90, p = 0.02),
after adjustment for covariates, women on the second ter-
tile showed a 16 percent greater Incidence Rate of miscar-
riage although it was not statistically significant (p = 0.61).
When the plasma/blood Pb ratio was analyzed as a con-
tinuous variable, we documented that an increment of 0.1
percentage points in the plasma/blood Pb ratio is associ-
ated with a 12 percent greater incidence rate of abortion
(IRR = 1.12, p = 0.02); both models are presented in table
2. These models included schooling as a proxy of socioe-
conomic status, however, this variable was not found to
be a determinant of the incidence of abortions and did
not seem to exert a confounding effect on the PPb/BPb
effect estimate (IRR for continuous PPb/BPb ratio without
adjustment for schooling was 1.121, p = 0.018). When we
tested models including whole blood, plasma or bone Pb
concentrations as predictor variables instead of the
plasma-to-blood Pb ratios, no significant association with
history of spontaneous abortion was found; a comparison
Table 2: Poisson regression models of history of abortion. Mexico 
City, Mexico, 1997–2004
Variable (units) Continuous model Quantiles model
IRR* IRR*
Plasmatic Pb fraction† 1.123
[0.017]
Plasmatic Pb fraction tertiles
1st 1.00
--
2nd 1.161
[0.612]
3rd 1.903
[0.015]
Age (years) 0.985 0.984
[0.477] [0.432]
Schooling (years) 1.025 1.021
[0.386] [0.455]
Poisson multiple regression models of the rate of spontaneous 
abortions featuring continuous (left column) or categorized (right 
column) plasma/blood Pb ratio as predictor variables, both models are 
adjusted for age and schooling
* Incidence Rate Ratio, p-values in brackets
† IRR for a 0.1 percentage point increase in the plasmatic fraction of 
Pb
Table 1: Characteristics of participants. Mexico City, Mexico, 1997–2004
All subjects (n = 207) No miscarriages (n = 136) ≥ 1 miscarriage (n = 71)
Variable Mean SD† Mean SD Mean SD p*
Age (years) 27.76 5.33 27.57 4.88 28.11 6.13 0.60
Years in school 9.4 4.04 9.49 3.82 9.23 4.45 0.90
Pregnancies 1.65 0.90 1.38 0.64 2.17 1.08 <0.01
Miscarriages 0.42 0.67 -- -- 1.23 0.57 --
Blood Pb (µg/L) 62.4 44.82 64.73 49.46 57.95 34.09 0.37
Plasma Pb (µg/L) 0.14 0.13 0.13 0.13 0.14 0.13 0.15
Plasma Pb/Blood Pb ratio (%) 0.22 0.14 0.21 0.13 0.25 0.17 0.02
* Mann-Whitney test
† SD: standard deviation
Regression of the plasma/blood Pb ratio on the number of miscarriages. Mexico City, Mexico, 1997–2004Figure 2
Regression of the plasma/blood Pb ratio on the 
number of miscarriages. Mexico City, Mexico, 1997–
2004. Simple ordinary least squares regression model of the 
plasma/blood Pb ratio of lead as a function of the lifetime 
number of spontaneous abortions.
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BMC Pregnancy and Childbirth 2007, 7:22 http://www.biomedcentral.com/1471-2393/7/22of the effect estimates of the different Pb biomarkers is
presented in table 3. We also tested for an interaction
between bone Pb concentrations and the plasma/blood
Pb ratio; according to our hypothesis, we could expect the
effect of bone Pb on history of miscarriage to be greater on
those women with higher ratios. We found the interaction
term to be in the expected direction in the patella model
(interaction IRR = 1.14, p = 0.21), but no significant inter-
action was observed in the tibia model (interaction IRR =
1.01, p = 0.99).
Cord blood lead levels were measured in a sample of 206
subjects, of whom 113 mothers had valid plasma Pb
measurements. We performed a secondary analysis on
these mother-child pairs, regardless of them being first
pregnant, to assess if plasma to blood Pb ratios were cor-
related to cord blood lead levels. Cord blood was appar-
ently correlated with the plasma/whole blood Pb ratio;
children whose mothers were in the upper tertile of the
plasma/blood Pb ratio in the first trimester of pregnancy
had a mean cord blood Pb of 4.61 µg/dL, compared with
5.03 and 6.36 µg/dL corresponding to the 2nd and 3rd ter-
tile (p-value for trend = 0.06).
Discussion
The results obtained by this study suggest that the plasma/
blood Pb ratio could be viewed as a marker of susceptibil-
ity for lead toxicity. Our findings are consistent with stud-
ies relating blood lead and risk of spontaneous abortion
[1]; a high plasma/blood Pb ratio implies more circulat-
ing lead is free to cross the placenta at a given blood lead
level. This is consistent with our finding of a correlation
between plasma/blood Pb ratios and cord blood Pb con-
centration at birth. If inter-individual factors such as pol-
ymorphisms of the ALAD gene determine the plasma/
blood lead ratio [5], then some women, if exposed to lead
during pregnancy, would be at increased risk of fetal lead
exposure. The rationale for the latter idea is that if a preg-
nant woman is acutely exposed to lead from, for example,
eating from a lead-glazed pot, her erithrocytic lead bind-
ing capacity will determine how much lead remains free
in plasma and potentially reaches the fetus. This hypothe-
sis is consistent with our observations: fetuses of women
who tend to have a higher plasma/blood Pb ratio would
be more susceptible to lead exposure and therefore these
women would have a history of spontaneous abortions in
previous pregnancies. In accordance with our hypothesis,
a lack of a strong association between plasma Pb concen-
trations and history of previous occurrence of abortions
was indeed observed in our sample as presented in table
3. The relatively large effect estimates of bone Pb are
worthwhile mentioning, since it would be expected that
women with a high lead burden are at elevated risk of
spontaneous abortion. Furthermore, the positive patella
Pb-ratio interaction term estimate suggests that the associ-
ation between bone Pb and history of abortion is greater
in those women with higher plasma/blood Pb ratios,
which is in accordance to the hypothesis presented here.
However, the small sample size of women with valid bone
Pb measurements in our study prevented us from further
exploring this hypothesis and reaching any definitive con-
clusion.
Our study has several limitations worth discussing. Given
we are trying to find an association between a biomarker
measured in the present time to events occurred years
before, no causal relationship can be established. How-
ever, under the assumption that certain factors that deter-
mine the percentage of free circulating lead in humans
remain constant between pregnancies, these findings
would imply that women who have a lower red cell bind-
ing capacity for circulating lead may be at increased risk of
suffering from spontaneous abortion. A second limitation
relies on the fact that history of miscarriage was self-
reported. This has the limitation that some women may
suffer a spontaneous abortion without knowing that they
were pregnant, while other women desirous of being preg-
nant may also report a spontaneous abortion without
actually being pregnant. Nevertheless, this imprecision in
the number of reported miscarriages is unlikely to be cor-
related to the plasma/blood Pb ratio and therefore our
estimates are unlikely to be biased. This random measure-
ment error of the outcome, however, may be reflected in
imprecise effect estimates.
A different issue is that our sample constitutes a relatively
small fraction of the cohorts which it arose from. If some-
how the probability of being selected into the study sam-
ple was related to both plasma/blood Pb ratios and the
number of miscarriages, selection bias could ensue. In
order to test if being selected into the final sample
depended on observed characteristics of the subjects,
especially those related to the outcome and the exposure,
Table 3: Incidence Rate Ratios of miscarriage comparing 
different biomarkers of lead exposure. Mexico City, Mexico, 
1997–2004
Biomarker IRR* p
Plasma Pb 1.12 0.22
Blood Pb 0.93 0.56
Plasma/Blood Pb ratio 1.18 0.02
Patella Pb† 1.15 0.39
Tibia Pb‡ 1.07 0.56
Comparison of incidence of spontaneous abortion rate ratios per 
increase of one standard deviation of several biomarkers of lead 
exposure. Note: Each line features an effect estimate obtained by 
separate Poisson regression models.
* Incidence Rate Ratio, adjusted for age and schooling.
† n = 95
‡ n = 153Page 6 of 8
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BMC Pregnancy and Childbirth 2007, 7:22 http://www.biomedcentral.com/1471-2393/7/22we fitted the following empirical model by means of logis-
tic regression:
ln(pi/1 - pi) = α0 + α1Ai + α2BPbi + α3Ci + X'iβ (8)
Where pj is a the probability of participation in the study,
Ai denotes the number of spontaneous abortions for the i-
th subject; BPbi is the blood lead concentration of the sub-
ject, Ci is an indicator variable for the subject's cohort and
X'i is a vector of individual characteristics such as age,
number of years in school, number of pregnancies, weight
and height (Table 4). Using this approach, we found no
evidence of selection bias; neither of the explored varia-
bles was associated to the probability of participating in
the study except for the cohort indicator. The reason for
the latter is the greater percentage of subjects in the first
cohort who had a plasma Pb measurement and were
therefore included in the study sample.
Another limitation was our inability to address the issue
of lead and risk of spontaneous abortion in current preg-
nancies since women were recruited past the point at
which spontaneous abortion usually occurs, and as a con-
sequence the incidence of abortion in the study cohort
was very small (1.3 percent), trying to estimate the effect
of lead on the outcome of this particular pregnancy will be
likely biased since women who miscarried before week 10
(including events possibly due to lead) had zero probabil-
ity of being included in this sample. Abortions in past
pregnancies could have occurred at any gestational age
and thus our estimates would not be affected by this issue.
However, there is a possibility that, if our hypothesis is
true, women with very high plasma/blood Pb ratios could
suffer from frequent miscarriages. For such women, the
probability to reach 10 weeks of gestation and become eli-
gible for this study would be low. If this were the case, it
is likely that the true effect of the plasma/blood Pb ratio
on the risk of miscarriage is underestimated by our study.
This possibility is supported by the data as the mean of the
plasma/blood Pb ratio in our study sample (0.22 percent)
was lower than that found in a sample of comparable
non-pregnant Mexico City residents (0.31 percent) using
the same methodology for plasma and blood Pb measure-
ment [12].
Finally, we should note that social class could be viewed
as an important potential confounder. Since both cohorts
had the limitation of not registering a socioeconomic
index, the models we presented adjust for schooling as a
proxy of socioeconomic status. The fact that it did not
seem to act as a confounder is consistent with the idea that
plasma/blood Pb ratios are governed by biological indi-
vidual characteristics rather than social factors. This is
reflected on the finding that schooling was not correlated
with the plasma/blood Pb ratio in our study sample
(Spearman's ρ = -0.03, p = 0.67).
Conclusion
Our results constitute evidence that the history of sponta-
neous abortion is related to the plasma/blood Pb ratio,
which could be due to a greater availability of placental
barrier-crossing Pb for a given blood Pb concentration in
some women. Nevertheless, specifically designed longitu-
dinal studies on this issue will be necessary to verify these
hypotheses. Assessing the influence of genetic polymor-
phisms of lead binding proteins on the probability of suf-
fering from miscarriage or other reproductive outcomes
will be very important to identify groups particularly sus-
ceptible to the effects of lead exposure during pregnancy.
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